Pharmafile Logo

Ogilvy PR

David Youds, Barney Mayles, Resonant Group

RESONANT GROUP ACQUIRES PR BUSINESS

Affirms Resonant’s mission to enable effective engagement in health

Bedrock Healthcare Communications

Onyx Health Launch VR Learning Platform in Response to COVID-19

Onyx Health are launching a new Interactive Learning Environment (ILE) to revolutionise healthcare communication

Onyx Health

Onyx Health Wins New MedTech Client

Onyx Health have recently bagged a new business win with Cambridge based MedTech company Medovate to launch their pioneering medical device SAFIRA in the United States

Onyx Health

Onyx Health strengthens its top team with senior appointment

Onyx Health have recently welcomed back Alex Gandhi as Account Director to strengthen their senior management team

Onyx Health

- PMLiVE

Ogilvy and Pulsar reveals latest ‘social check-up’ report

Social media report names Novo Nordisk as most engaging pharma company

- PMLiVE

Endo faces industry-first FDA call to pull its opioid painkiller

Misuse of Opana ER has been associated with a ‘serious’ HIV and hep C outbreaks

- PMLiVE

Consilium Strategic Communications wins Vectura account

Will advise on financial and corporate PR following SkyePharma merger

PEGASUS WINS COMMUNIQUÉ 2015 ‘EXCELLENCE IN PATIENT/CONSUMER HEALTH PROGRAMMES’ AWARD FOR RARE DISEASE AWARENESS CAMPAIGN

Pegasus, the UK’s leading independent health communications consultancy, picked up the ‘Excellence in Patient/Consumer Health Programmes’ award at last week’s prestigious Communiqué Awards 2015 with its ‘Faces of HAE’ campaign...

Evoke Mind+Matter

- PMLiVE

Endo buys Par for $8bn as M&A mania marches on

Acquisitionwill make Endo the fifth largest generics company in the US

- PMLiVE

Pharma growing its use of social media – report

New data also highlights who leads the way in integrated social media marketing

- PMLiVE

Ogilvy CommonHealth releases pharmacy report

The Power of Pharmacy debates its role and the change it faces

- PMLiVE

Valeant raises offer for Salix; rival Endo bows out

Has increased bid to $173 per share in cash

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links